Apart from protecting our participants, rescheduling non-essential gathering and travel also aims to contain the spread of coronavirus disease and protect the health system which will otherwise be overwhelmed. Thank you very much for your understanding in the complex situation.
Event Committee
BIT's 13th Annual World Cancer Congress(WCC-2021) will be held during July 20-22, 2021 in Lisbon, Portugal.
WCC-2021 is a dedicated event where you will have the opportunity to learn about new developments in the
field of cancer research, cancer therapies, and new drug trials, share aspects of your own work by submitting
an oral presentation or poster. With the participation of outstanding international experts, we hope
productive discussions would stimulate new creative ideas to translate new discoveries into better practice
and application. We hope your participation would contribute to your professional development and
relationships. Wish you enjoy the conference.
 |
Dr. Jukka H. Meurman Professor, University of Helsinki & Helsinki University Hospital, Finland |
 |
Dr. Rossitza Lazova Director of Dermatopathology in San Jose, California Skin Institute, USA |
 |
Dr. Yi Sun, Professor, University of Michigan, Comprehensive Cancer Center, USA |  |
Dr. Sinerik Ayrapetyan, Professor, UNESCO Chair-Life Sciences International Postgraduate Educational Center, Coordinator of UNESCO/UNITWIN Interregional Network on PhD Education and Research in Biophysics, Biotechnology and Environmental Health, Armenia |  |
Dr. Zoe S. Walters, Lecturer & Programme Lead , Faculty of Medicine, University of Southampton, UK |
 |
Dr. Ioannis Papasotiriou, Medical Director, Director, R.G.C.C. INTERNATIONAL GmbH, Switzerland |  |
Dr. Anna Juncker-Jensen, Senior Scientist, NeoGenomics, USA |  |
Dr. Shaul Mordechai, Professor & Head, Biomedical Spectroscopy, Ben Gurion University, Israel |
 |
Dr. Timothy N Hembree, Assistant Professor, University of South Florida, USA |  |
Dr. Femida Gwadry-Sridhar, CEO & Founder, Pulse Infoframe Inc., Canada |  |
Dr. Robert L. Bard, Director, Bard Cancer Diagnostics, USA |
 |
Dr. Birgit Leibbrand, Medical Director, Salzetalklinik, Onkologische Rehabilitation, Germany |  |
Dr. Iouri Borissevitch, Full Professor, Universidade de São Paulo, Brazil |  |
Dr. Mohamed El-Sheemy, Research Development, Lincoln County Hospital, UK |
 |
Dr. Paul De Leyn, Chairman, UZ Leuven, Belgium |  |
Dr. Mitsuru Sasako, Special Consultant Surgeon Yodogawa Christian Hospital, Japan |  |
Dr. Katya Ravid, Professor, Boston University School of Medicine, USA |
 |
Dr. Weiping Zhang, Director, The Third Affiliated Hospital of Zhejiang Chinese Medical University, China |  |
Dr. Hillary Klonoff-Cohen, Professor, University of Illinois Urbana-Champaign, USA |  |
Dr. Chi-Min Shih, General Pathologist Chia-Yi Hospital, Ministry of Health and Welfare, Taiwan |
 |
Dr. Michael Friedrich, Head, HELIOS Hospital, Germany |  |
Dr. Tomiyo Nakamura, Professor, Ryukoku University, Japan |  |
Dr. Asha Ramsakal, Associate Professor, H. Lee Moffitt Cancer Center, USA |
Lisbon is the capital and the largest city of Portugal. With an estimated population of 505,526 within its administrative limits in an area of 100.05 km, Lisbon's urban area extends beyond the city's administrative limits with a population of around 2.8 million people, being the 11th-most populous urban area in the European Union. About 3 million people live in the Lisbon Metropolitan Area, including the Portuguese Riviera, (which represents approximately 27% of the country's population). It is mainland Europe's westernmost capital city and the only one along the Atlantic coast. Lisbon lies in the western Iberian Peninsula on the Atlantic Ocean and the River Tagus. The westernmost areas of its metro area form the westernmost point of Continental Europe, which is known as Cabo da Roca, located in the Sintra Mountains.
As part of the BIT's 13th Annual World Cancer Congress (WCC-2021), an exhibition space will provide a unique opportunity for exhibitors to showcase their products and services to participants with interests in all areas of cancer. Developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent and repeated opportunities for delegates to visit the exhibits.
Exhibitors' advantages
• The exhibition will be visited by participants of the
conference it means by your authentic target group from China and other countries.
• The exhibitors have the opportunity to present their exhibits more detailed, and have the opportunity for
longer discussion with inquiring visitors – in most cases specialists – than during session discussions.
  |
Exhibition Date: |
BIT Group Global Ltd.
Dr. Vladimir Lazar
Chief Scientific and Operating Officer
WIN Consortium, France
Dr. Ashok Srivastava
Chief Executive Officer & Chief Medical Officer, ClinFomatrix, Cure Pharmaceuticals, Inc, USA
Contact Us: Email:melinda@bitcongress.com
Company Name: NOVA SILK ROAD SARL, Company Address: 37 rue des Mathurins, Paris, France
Copyright © 2008-2020 BIT Congress